# A perspective on the future of heart failure research

**Authors:** Alyssa C. Vadovsky, Eunji Jeong, Sandeep Banga, Jason N. Bazil

PMC · DOI: 10.1016/j.jmccpl.2026.100835 · Journal of Molecular and Cellular Cardiology Plus · 2026-02-07

## TL;DR

This paper discusses the future of heart failure research, focusing on bioenergetic abnormalities and a new hypothesis involving oxidative stress and mitochondrial calcium phosphate granules.

## Contribution

The paper introduces a novel hypothesis linking oxidative stress and mitochondrial calcium phosphate granules to heart failure bioenergetic abnormalities.

## Key findings

- Heart failure is associated with bioenergetic abnormalities, primarily due to mitochondrial dysfunction.
- A new hypothesis suggests oxidative stress and mitochondrial calcium phosphate granules may cause depressed oxidative capacities in heart failure.
- The paper proposes innovative research strategies to explore uncharted domains in heart failure etiology.

## Abstract

Heart failure is chronic condition that is diagnosed when the heart is no longer able to pump enough blood to meet the physiological needs of the body. It is a progressive condition and typically manifests early on as exercise intolerance due to insufficient cardiac output before developing into the end stage disease. Nearly 7 million U.S. adults currently live with some form of heart failure, roughly accounting for 14% of all deaths. Various etiologies of heart failure have been identified which stem from a constellation of perfusion, pressure, morphological, electrical, and/or metabolic origins. An underlying issue for nearly all forms of heart failure is what is known as bioenergetic abnormalities. Although mitochondrial dysfunction is widely implicated, the precise molecular mechanisms underlying bioenergetic abnormalities remain incompletely understood. In this commentary, we describe the most prevalent heart failure types and offer a possible mechanism capable of explaining these bioenergetic abnormalities. We explore a novel hypothesis that links oxidative stress caused by intrinsic and extrinsic factors, which leads to depressed oxidative capacities induced by the presence of mitochondrial calcium phosphate granules. This hypothesis is supported by evidence previously reported in literature and may offer a new etiology of heart failure. We conclude by outlining a bold strategy to advance heart failure research through innovative approaches and unexplored domains.

Unlabelled Image

## Linked entities

- **Diseases:** heart failure (MONDO:0005252)

## Full-text entities

- **Genes:** TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, PRDX3 (peroxiredoxin 3) [NCBI Gene 10935] {aka AOP-1, AOP1, HBC189, MER5, PPPCD, PRO1748}, RYR2 (ryanodine receptor 2) [NCBI Gene 6262] {aka ARVC2, ARVD2, RYR-2, RyR, VACRDS, VTSIP}, CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818] {aka CAMK, CAMK-II, CAMKG, MRD59}, PLIN1 (perilipin 1) [NCBI Gene 5346] {aka FPLD4, PERI, PLIN}, PFAS (phosphoribosylformylglycinamidine synthase) [NCBI Gene 5198] {aka FGAMS, FGAR-AT, FGARAT, GATD8, PURL}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, CS (citrate synthase) [NCBI Gene 1431], RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, PDP1 (pyruvate dehydrogenase phosphatase catalytic subunit 1) [NCBI Gene 54704] {aka PDH, PDP, PDPC, PDPC 1, PPM2A, PPM2C}
- **Diseases:** mitochondrial defect (MESH:C565376), inflammation (MESH:D007249), right (MESH:C535682), fibrosis (MESH:D005355), Volume overload (MESH:D019190), bioenergetic abnormality (MESH:D000014), reperfusion injury (MESH:D015427), femoral artery plaques (MESH:D016893), myocardial stiffness (MESH:C566112), Hypertension (MESH:D006973), LV hypertrophy (MESH:D017379), cardiomyocyte death (MESH:D003643), Atherosclerosis (MESH:D050197), Mitochondrial dysfunction (MESH:D028361), Myocardial infarction (MESH:D009203), right ventricular dysfunction (MESH:D018497), dyspnea (MESH:D004417), cardiovascular disease (MESH:D002318), infections (MESH:D007239), DCM (MESH:D002311), IHD (MESH:D017202), ischemic (MESH:D002545), Endothelial dysfunction (MESH:D014652), concentric hypertrophy (MESH:D006984), diabetes (MESH:D003920), insufficient cardiac output (MESH:D002303), renal sodium (MESH:C562576), pulmonary and peripheral edema (MESH:D011654), vascular dysfunction (MESH:D002561), abnormal diastolic function (MESH:D006337), impaired ventricular relaxation (MESH:D018754), ventricular dilatation (MESH:C566255), diastolic dysfunction (MESH:D018487), peripheral artery disease (MESH:D058729), Heart failure (MESH:D006333), Calcium (MESH:D002128), hypoxic (MESH:D002534), AS (MESH:D001024), obesity (MESH:D009765), depressed (MESH:D003866), cardiomyopathies (MESH:D009202), atrial enlargement (MESH:D006332), ventricular remodeling (MESH:D020257), stroke (MESH:D020521), coronary artery disease (MESH:D003324), contractile dysfunction (MESH:D006331), ischemia (MESH:D007511), metabolic diseases (MESH:D008659), necrosis (MESH:D009336), HFrEF (MESH:D054143), chronic (MESH:D002908), pulmonary hypertension (MESH:D006976), HFpEF (MESH:D054144)
- **Chemicals:** pyruvate (MESH:D019289), Xenochemicals (-), succinate (MESH:D019802), Pi (MESH:D010716), proton (MESH:D011522), oxygen (MESH:D010100), catecholamines (MESH:D002395), chlorine (MESH:D002713), phosphocreatine (MESH:D010725), carbohydrate (MESH:D002241), fatty acid (MESH:D005227), polyvinyl chloride (MESH:D011143), ATP (MESH:D000255), rotenone (MESH:D012402), polystyrene (MESH:D011137), per- and polyfluoroalkyl substances (MESH:D005466), free fatty acids (MESH:D005230), Iron (MESH:D007501), lipid (MESH:D008055), calcium phosphate (MESH:C020243), NADH (MESH:D009243), quinone (MESH:C004532), glucose (MESH:D005947), polyethylene (MESH:D020959), NO (MESH:D009569), ROS (MESH:D017382), heavy metals (MESH:D019216), calcium (MESH:D002118)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** R4496C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915262/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915262/full.md

## References

183 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915262/full.md

---
Source: https://tomesphere.com/paper/PMC12915262